N-acetylsulfanilyl chloride
- Generic Name
- N-acetylsulfanilyl chloride
- Drug Type
- Small Molecule
- Chemical Formula
- C8H8ClNO3S
- CAS Number
- 121-60-8
- Unique Ingredient Identifier
- LIX4M9AIVM
- Background
ASC has been investigated for the screening of Patients Undergoing Screening or Surveillance Colonoscopy.
DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Gannex Pharma Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04845646
- Locations
- ๐บ๐ธ
ICON early Phase Services LLC, San Antonio, Texas, United States
Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects
Phase 1
Completed
- Conditions
- Overweight and ObesityNAFLDHyperlipidemia
- Interventions
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Gannex Pharma Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04686994
- Locations
- ๐จ๐ณ
Hunan provincial people's hospital, Changsha, Hunan, China
A Study of the Relative Bioavailability of ASC41 in Healthy Subjects
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04527250
- Locations
- ๐จ๐ณ
Hunan provincial people's hospital, Changsha, Hunan, China
Effects of ASC Secretome on Human Osteochondral Explants
Completed
- Conditions
- Osteoarthritis
- First Posted Date
- 2020-01-10
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- Target Recruit Count
- 36
- Registration Number
- NCT04223622
- Locations
- ๐ฎ๐น
IRCCS Istituto Ortopedico Galeazzi, Milano, MI, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath